Unknown

Dataset Information

0

Design, Synthesis, and Cytotoxic Analysis of Novel Hederagenin?Pyrazine Derivatives Based on Partial Least Squares Discriminant Analysis.


ABSTRACT: Hederagenin (He) is a novel triterpene template for the development of new antitumor compounds. In this study, 26 new He?pyrazine derivatives were synthetized in an attempt to develop potent antitumor agents; they were screened for in vitro cytotoxicity against tumor and non-tumor cell lines. The majority of these derivatives showed much stronger cytotoxic activity than He. Remarkably, the most potent was compound 9 (half maximal inhibitory concentration (IC50) was 3.45 ± 0.59 ?M), which exhibited similar antitumor activities against A549 (human non-small-cell lung cancer) as the positive drug cisplatin (DDP; IC50 was 3.85 ± 0.63 ?M), while it showed lower cytotoxicity on H9c2 (murine heart myoblast; IC50 was 16.69 ± 0.12 ?M) cell lines. Compound 9 could induce the early apoptosis and evoke cell-cycle arrest at the synthesis (S) phase of A549 cells. Impressively, we innovatively introduced the method of cluster analysis modeled as partial least squares discriminant analysis (PLS-DA) into the structure?activity relationship (SAR) evaluation, and SAR confirmed that pyrazine had a profound effect on the antitumor activity of He. The present studies highlight the importance of pyrazine derivatives of He in the discovery and development of novel antitumor agents.

SUBMITTER: Fang K 

PROVIDER: S-EPMC6213900 | biostudies-other | 2018 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

Design, Synthesis, and Cytotoxic Analysis of Novel Hederagenin⁻Pyrazine Derivatives Based on Partial Least Squares Discriminant Analysis.

Fang Kang K   Zhang Xiao-Hua XH   Han Yao-Tian YT   Wu Gao-Rong GR   Cai De-Sheng DS   Xue Nan-Nan NN   Guo Wen-Bo WB   Yang Yu-Qin YQ   Chen Meng M   Zhang Xin-Yu XY   Wang Hui H   Ma Tao T   Wang Peng-Long PL   Lei Hai-Min HM  

International journal of molecular sciences 20180930 10


Hederagenin (<b>He</b>) is a novel triterpene template for the development of new antitumor compounds. In this study, 26 new <b>He</b>⁻pyrazine derivatives were synthetized in an attempt to develop potent antitumor agents; they were screened for in vitro cytotoxicity against tumor and non-tumor cell lines<i>.</i> The majority of these derivatives showed much stronger cytotoxic activity than <b>He</b>. Remarkably, the most potent was compound <b>9</b> (half maximal inhibitory concentration (IC<su  ...[more]

Similar Datasets

| S-EPMC6316795 | biostudies-literature
| S-EPMC10765869 | biostudies-literature
| S-EPMC7581254 | biostudies-literature
| S-EPMC7487730 | biostudies-literature
| S-EPMC6421834 | biostudies-literature
| S-EPMC5512430 | biostudies-literature
| S-EPMC9975091 | biostudies-literature
| S-EPMC4650675 | biostudies-literature
| S-EPMC6349410 | biostudies-literature
| S-EPMC6271630 | biostudies-literature